The Tokyo-Silicon Valley MedTech Launchpad

Apply now

Tokyo MedTech 2026 Showcase

Demo Day 2026: The Results

Watch the full event and individual company pitches below. Tokyo’s most promising MedTech innovators present their breakthrough medical technologies to global investors.

Meet the pitching companies

See the companies’ pitches. Click the button below to contact the startups.
Contact Inquiries
01 / GASTROENTEROLOGY / SURGICAL DEVICES

GEStiC

Developing an electrically stimulated intestinal catheter that moves itself deeper into the bowel to relieve small bowel obstruction without surgery.
02 / DIGITAL HEALTH / DIABETES

Provigate

Developing glucoreview, a weekly glycated albumin test paired with an AI app and human coaching for people with type 2 diabetes who don’t use insulin.
03 / NEUROTECHNOLOGY / BCI

JiMED

Developing a fully implantable, wireless brain-computer interface that lets people with ALS or spinal cord injury control external devices.
04 / WOMEN'S HEALTH / DIAGNOSTICS

CraneBio

Using DNA origami technology to build an at-home HPV screening test for women who face barriers to regular screening.
05 / SURGICAL ROBOTICS

Riverfield

Japan’s first domestic surgical robot, which uses air-driven (pneumatic) arms to give surgeons a sense of grip force.
06 / CANCER THERAPEUTICS

FerroptoCure

Developing an oral cancer drug that triggers ferroptosis, a form of cell death, by blocking two defenses that cancer cells rely on.
07 / WOUND CARE / DIABETIC FOOT

Sachilles

Developing a treatment system for infected diabetic foot ulcers that combines foot-shaped negative pressure therapy, off-loading, and rapid disinfection.
08 / CARDIOVASCULAR

Aortic Technologies

Developing an automated device that joins the aorta during open aortic surgery, aiming to cut this step from about 60 minutes to 10.
09 / BRAIN HEALTH / AI DIAGNOSTICS

Splink

Brain health company offering cognitive screening and AI analysis of brain scans to detect dementia early.
10 / WOMEN'S HEALTH / EXTRACORPOREAL THERAPY

Hoshino Labs

Developing a blood filter that removes the placental exosomes that cause preeclampsia, plus a blood test that predicts the condition about four weeks early.
11 / REPRODUCTIVE TECHNOLOGY / AI

ARCS

Developing an AI add-on for IVF lab microscopes that analyzes and ranks sperm in real time to help embryologists choose sperm for ICSI.
12 / NEUROREHABILITATION

LifeScapes

A non-invasive brain-computer interface that combines EEG with a robotic hand brace to help stroke and spinal cord injury patients regain hand movement.
13 / NEUROTECHNOLOGY / BRAIN-MACHINE INTERFACE

Ruten

Developing brain-machine interface software and the Swallow Autopilot, a fully implanted system to restore swallowing in people with chronic dysphagia.
14 / AI / SOFTWARE AS A MEDICAL DEVICE

Ayumo

AI software that diagnoses walking disorders, starting with cervical myelopathy, from video recorded on a standard tablet.
Tokyo MedTech 2026 Showcase

Full event recording

Watch the judges’ questions and answers for each company.
MEET THE JURY

Expert Panel of Judges

Seiya Takahashi

Principal at DG Incubation (DGI)

A Principal at DG Incubation (DGI), the venture capital and incubation arm of the Digital Garage Group, working closely with startups to drive innovation.

Shinya Kasuga

General Partner, IT-Farm

IT-Farm is one of Japan’s first cross-border tech VC since 1999, investing in 150 startups across US, Europe, Asia, and Japan.

Gregg Shibata

Sr Principal, Corp-Dev, Blue Shield of California

Gregg Yoshito Shibata (柴田 義人) is a 25-year healthcare veteran who leads strategic investments at Blue Shield of California.

Minoru Sasaki

Director, Nippon Life Global Investors Americas, Inc.

Based in the Silicon Valley office of Nippon Life Global Investors Americas, Inc. (NLGIA), Minoru Sasaki invests in venture capital funds and startups.

Yohichi Sakagawa

Senior Manager, MedVenture Partners

Participated in investments for dozens of companies domestically and internationally, while also supporting corporate open innovation activities. Involved in strategic investment initiatives, including capital and business alliances.

Why Japan? Why Now?

Japanese startups build, but the world rarely sees.

Japan's market for medical devices is among the world's largest, and its research base is world class. Its hospitals run some of the highest procedure volumes anywhere. Its engineering culture produces devices with a precision and reliability that clinicians notice immediately.

And yet a striking amount of that innovation never crosses the Pacific. Language, regulatory distance, and a domestic market large enough to be comfortable have kept extraordinary technology inside Japan for years

That is changing, and this is the proof. Come and hear founders that are seeing the US as their main target market and building their products for it.

Demo Day is where that starts.

Who is behind this

The Tokyo Silicon Valley MedTech Launchpad (TSVML) is an accelerator with a single focus: bringing Japan's most advanced medical technology to the United States.

We work with startups and founders on the things that actually decide whether a Japanese MedTech company succeeds in America: Product market fit, FDA pathway and regulatory strategy, clinical validation and site relationships, reimbursement, distribution and commercial partnerships, and fundraising from US investors.

Launched in early 2026, our current cohort is 20 companies, ranging from pre-formation spinouts led by professors at Japan's top medical universities through to companies with regulatory approval, revenue and hospital deployments at home.

TSVML is supported by the Tokyo Metropolitan Government as part of its SUTeam program.